NetworkNewsBreaks – Isracann Biosciences Inc. (CSE: IPOT) Begins Trading on the CSE
A technical420 editorial published on Thursday and written by Anthony Varrell highlights Isracann Biosciences’ (CSE: IPOT) new listing on the Canadian Securities Exchange (“CSE”). Isracann is an Israeli-based cannabis company focused on becoming a premier, low-cost cannabis producer. Per the article, the listing signifies a global opportunity and demonstrates that the company is one to watch for various reasons, including its status as Israel’s first pure play cannabis firm to list in Canada and its plans to execute on a 230,000 sq. ft. hybrid greenhouse that is fully funded. To view the full article, visit http://nnw.fm/dr6Uo About Isracann Biosciences Inc.…







